TEVA FDA Thursday, December 4, 2008 +0.30 Positive

FDA Approves Unknown Drug — TEVA PHARMS

Teva Pharmaceuticals announced FDA approval of Pediatric ZDV, significantly expanding its HIV oral solution portfolio and reinforcing its dominant market position in this critical pediatric antiretroviral segment. The approval is expected to bolster commercial sales for the generic antiviral as it increases competition in the orphan indication.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed